Dr. Israel Manzanedo is a Consultant General and Digestive Surgeon at the Department of General and Digestive Surgery, at the Fuenlabrada University Hospital in Madrid, Spain. He graduated in Medicine in 2006, specialized in General and Digestive Surgery in 2012, and earned his PhD cum laude from the Rey Juan Carlos University of Madrid in 2021.
Since 2014, he has worked in the Peritoneal Carcinomatosis Unit at the hospital, one of the most prestigious in Spain. His main areas of expertise are peritoneal oncologic surgery and esophagogastric surgery.
As an expert in peritoneal oncologic surgery, he has given numerous presentations in various national and international courses and conferences.
He is the author or co-author of numerous articles in high-impact journals with an H index of 8.
He has also written chapters in several books and collaborated on various consensus documents and clinical guidelines.
He is a member of the European Society for Surgical Oncology (ESSO), a member of the Spanish Society of Surgical Oncology (SEOQ), a member of the Spanish Group of Peritoneal Oncologic Surgery (GECOP), and the Spanish Association of Surgeons (AEC).
Selected publications from PubMed
Interval Cytoreductive Surgery and Cisplatin- or Paclitaxel-Based HIPEC for Advanced Ovarian Cancer.
González Sánchez S, García Fernández J, Cascales-Campos PA, Gonzalez Gil A, Manzanedo I, Pereira Perez F, Díaz Gómez D, González-de Pedro C, Asensio Diaz E, Pacheco Sanchez D, Prada-Villaverde A, Jaén Torrejimeno I, Lacueva J, Caravaca-Garcia I, Torres-Melero J, Sanchez-García S, Díaz Reques E, Ramírez Plaza C, Gutiérrez-Calvo A, González Bayón L, Morales-Soriano R, López-Mozos F, Bjelic L, Galindo Álvarez J, Marcello Fernandez ME, Turienzo Santos E, Titos García A, Álvarez Seoane R, Artiles Armas M, Garaulet ET, Villarejo Campos P, Boldó Roda E, Rihuete Caro C, García Fadrique A, Arjona-Sánchez Á, REGECOP collaborators
JAMA Netw Open. 2025 Jun 2;8(6):e2517676 doi: 10.1001/jamanetworkopen.2025.17676.
OVA-LEAK: Prognostic score for colo-rectal anastomotic leakage in patients undergoing ovarian cancer surgery.
Lago V, Segarra-Vidal B, Cappucio S, Angeles MA, Fotopoulou C, Muallem MZ, Manzanedo I, Iglesias JLS, Chacón E, Padilla-Iserte P, Fagotti A, Ferron G, Kluge L, Vargiu V, Del M, Scambia G, Minig L, Tejerizo Á, Segovia MG, Cascales-Campos PA, OVA-LEAK Collaborative Group, Hervás D, Domingo S
Gynecol Oncol. 2022 Oct;167(1):22-27 doi: 10.1016/j.ygyno.2022.08.004.
Intraperitoneal hyperthermic chemotherapy after cytoreduction in patients with peritoneal metastases from endometrial cancer. The next frontier?
Navarro-Barrios Á, Gil-Martínez J, Ramos-Bernardo I, Barrios P, Muñoz-Casares C, Torres-Melero J, Pereira F, Manzanedo I, Arjona Á, Martínez-Regueira F, Cascales-Campos PA
Surg Oncol. 2020 Jun;33:19-23 doi: 10.1016/j.suronc.2019.12.002.
Help your network discover Dr. Israel Manzanedo's clinical expertise.
